Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Higher Consumption of Sugar Substitutes Linked to Accelerated Cognitive Decline and Memory Loss in Middle-Aged Adults
Neuroscience & Brain Research

Higher Consumption of Sugar Substitutes Linked to Accelerated Cognitive Decline and Memory Loss in Middle-Aged Adults

Rifan Muazin Jul 19, 2026 0

A longitudinal study published in Neurology, the medical journal of the American Academy of Neurology, has identified a significant association…

Read More
Advanced Materials Science

New solid-state material converts sunlight into higher-energy UV light

Nila Kartika Wati Jul 12, 2026 0

In a breakthrough that challenges traditional thermodynamic intuition, researchers at Kyushu University have announced the development of a novel solid-state…

Read More
Clinical Diagnostics & Pathology

Higher Midlife Vitamin D Levels Linked to Lower Tau Protein Years Later, Offering New Insight for Neurodegenerative Disease Research

Reynand Amr Wu May 14, 2026 0

A groundbreaking longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Chlorpyrifos Linked to Significantly Higher Risk of Parkinson’s Disease According to UCLA Health Study

Rifan Muazin Mar 19, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
MIT Researchers Map 3D Atomic Structure of Relaxor Ferroelectrics to Unlock New Frontiers in Materials Science and EngineeringRegional Bone Marrow Niches in the Skull Identified as Potent Reservoirs for Glioblastoma DefenseTWiV 1287: Ancient Herpesviruses and Modern DementiaRemepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ